iproniazid
Very Low / TechnicalTechnical, Historical, Medical
Definition
Meaning
A monoamine oxidase inhibitor (MAOI), formerly used as an antidepressant and antitubercular drug.
A historical hydrazine derivative that was the first clinically effective antidepressant. Its discovery in the 1950s led to the development of modern antidepressant therapies. It is now largely of historical interest in pharmacology and psychiatry.
Linguistics
Semantic Notes
Primarily refers to a specific chemical entity (C9H13N3O). Its use is almost exclusively historical; modern references typically occur in academic texts discussing the history of psychopharmacology.
Dialectal Variation
British vs American Usage
Differences
No significant differences in usage or spelling. The term is identical in both variants and confined to the same highly technical registers.
Connotations
Historical, pioneering, largely obsolete, associated with significant side-effect profile.
Frequency
Extremely rare in general language. Frequency is identical in both UK and US English, confined to specialised medical or historical discourse.
Vocabulary
Collocations
Grammar
Valency Patterns
the development of ~treatment with ~the discovery that ~Vocabulary
Synonyms
Neutral
Weak
Vocabulary
Antonyms
Usage
Context Usage
Business
Not used.
Academic
Used in historical reviews of pharmacology, psychiatry, and medicinal chemistry.
Everyday
Never used in everyday conversation.
Technical
The primary context; used in specialised medical, psychiatric, and pharmacological texts discussing drug history or MAOIs.
Examples
By Part of Speech
adjective
British English
- The iproniazid era was short-lived.
- They studied iproniazid metabolites.
American English
- The iproniazid discovery was accidental.
- Iproniazid research paved the way for new drugs.
Examples
By CEFR Level
- Iproniazid was an important drug in medical history.
- Doctors no longer prescribe iproniazid.
- The serendipitous discovery of iproniazid's antidepressant effects revolutionised psychiatry.
- Although effective, iproniazid was withdrawn due to hepatotoxicity and dietary restrictions.
Learning
Memory Aids
Mnemonic
Think 'I PROmise Not IAZY, I'm an ID' (a playful way to recall the drug class: I-promise-not-iazy-id, linking to its stimulating antidepressant effect).
Conceptual Metaphor
A FOUNDATIONAL KEY (it unlocked the door to modern antidepressant treatment).
Watch out
Common Pitfalls
Translation Traps (for Russian speakers)
- Do not confuse with 'pronos' or other Russian-sounding roots. It is a specific international non-proprietary name (INN).
- Avoid direct translation attempts; it is a loanword in Russian as 'ипрониазид'.
Common Mistakes
- Misspelling: 'iproniazide', 'iproniazid' (correct).
- Mispronouncing the 'zid' as 'zide'.
- Confusing it with isoniazid (a related antitubercular drug).
Practice
Quiz
Iproniazid is primarily significant for being:
FAQ
Frequently Asked Questions
No, it is historically significant but is no longer in clinical use due to its side-effect profile and the development of safer antidepressants.
It was originally developed as an antitubercular drug but was found to be effective against depression, leading to its use as the first MAOI antidepressant.
Its discovery in the 1950s provided the first pharmacological evidence that brain chemistry could be altered to treat depression, founding the field of psychopharmacology.
It is a monoamine oxidase inhibitor (MAOI), specifically a hydrazine derivative.